In this CME-certified, on-demand Webcast of a CCO symposium at SNO 2019, a panel of expert faculty reviews and discusses the latest data on the use of tyrosine kinase inhibitors for the treatment of glioblastoma.
In this downloadable slideset, Rimas V. Lukas, MD, spotlights NTRK fusions and TRK-targeted therapies for patients with GBM.
In this downloadable slideset, Manmeet S. Ahluwalia, MD, FACP, highlights regorafenib in the REGOMA trial and other multiple receptor kinase inhibitors for patients with GBM.
In this downloadable slideset, Tom Mikkelsen, MD, FRCPC, examines optimal clinical trial approaches for GBM therapies.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.